Long-Term Outcomes of the ADRENAL Trial
Long-Term Outcomes of the ADRENAL Trial
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In the ADRENAL trial, among adult patients with septic shock, hydrocortisone did not lead to lower mortality than placebo. Now, a prespecified secondary analysis shows that hydrocortisone did not affect mortality 6 months after randomization.
Alternative Titles
Full title
Long-Term Outcomes of the ADRENAL Trial
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2031421302
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2031421302
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMc1803563